Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438592 · ClinicalTrials.gov registry record
PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 924
- Enrollment target
NCT02438592 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 924 participants.
The verdict
NCT02438592 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 924 participants
- Enrollment target
Study Summary
This is an observational study involving retrospective and prospective medical record review covering a total maximum of 104 weeks (24 months) per subject. An Audio Computer- Assisted Self-Interview (ACASI) at study entry will assess demographic and psychosocial variables of study subjects. Data will also be collected to assess clinic level variables. Definitions of engagement, prescription of antiretroviral therapy (ART), and viral suppression in the Continuum of Care (CoC) will utilize common definitions including those by U.S. Department of Health and Human Services (DHHS) and Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB). Data will be collected in a large, simple trial design manner to provide all elements for both the primary and secondary outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 924 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02438592
The ClinicalTrials.gov registry entry for NCT02438592 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 924 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02438592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02438592 about?
NCT02438592 is a clinical study titled "PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders". This is an observational study involving retrospective and prospective medical record review covering a total maximum of 104 weeks (24 months) per subject. An Audio Computer- Assisted Self-Interview (ACASI) at study entry will assess demographic and psychosocial variables of study subjects. Data wil...
What is the current status of trial NCT02438592?
This trial is currently completed. The enrollment target is 924 participants. The study started on 2015-03. Estimated completion is 2016-02.
Who is sponsoring clinical trial NCT02438592?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.